Showing 1511-1520 of 2079 results for "".
“Natural” Remedies for Eczema: Evidence for the Alternative?
https://practicaldermatology.com/topics/general-topics/natural-remedies-for-eczema-evidence-for-the-alternative/22936/Limited data suggest the possibility that some natural agents may be particularly useful in the treatment of atopic dermatitis.Warts and All: A Treatment Update for Verruca Vulgaris
https://practicaldermatology.com/topics/general-topics/warts-and-all-a-treatment-update-for-verruca-vulgaris/21451/GLP-1 Receptor Agonists: Current Roles in Medicine
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-current-roles-in-medicine/48897/In recent years, the popularity of glucagon-like peptide 1 receptor agonists (GLP-1RAs) has skyrocketed, along with interest in clinical applications beyond diabetes and weight management. Here, we present a brief review of GLP-1RAs, including a history, a look at the mechanism of action, pivotal reEtiology, Autoinoculation, and Transmission: What Wart Patients Need to Know
https://practicaldermatology.com/topics/infections-infectious-disease/etiology-autoinoculation-and-transmission-what-wart-patients-need-to-know/23613/Taking time to educate patients can decrease their embarrassment and can lead them to share useful information.The Future of Treatment and Research for Giant Congenital Melanocytic Nevi
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-future-of-treatment-and-research-for-giant-congenital-melanocytic-nevi/57252/Congenital melanocytic nevi (CMN) have long posed a clinical paradox: lesions that are often benign in behavior yet burdened by a measurable risk of melanoma and significant psychosocial impact. Present at birth or emerging in early infancy, CMN vary widely in size, distribution, and long-term impliNew Rosacea Classification System Encourages
More Precise Assessment and Treatmenthttps://practicaldermatology.com/topics/practice-management/new-rosacea-classification-system-encourages-br-more-precise-assessment-and-treatment/20484/A look at the rationale behind the new classification system and what it means for clinicians.Tips for Management of Cutaneous Squamous Cell Carcinoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/tips-for-management-of-cutaneous-squamous-cell-carcinoma/57254/Cutaneous squamous cell carcinoma (cSCC) is one of the most common malignancies encountered in dermatologic practice. Current treatment guidelines for cSCC provide recommendations based largely on tumor risk classification, while emphasizing the importance of clinical judgment and patient-specific fBody Dysmorphic Disorder Screening Tools for the Dermatologist: A Systematic Review
https://practicaldermatology.com/topics/general-topics/body-dysmorphic-disorder-screening-tools-for-the-dermatologist-a-systematic-review-s/21231/Update on Isotretinoin, Depression, and Suicide: Appropriate Monitoring is Key
https://practicaldermatology.com/topics/general-topics/update-on-isotretinoin-depression-and-suicide-appropriate-monitoring-is-key/21859/Data have failed to show a direct relationship between isotretinoin use and depression or suicide, but the cumulative evidence suggests patients with severe acne require careful monitoring.Medical Dermatology Myths
https://practicaldermatology.com/topics/general-topics/medical-dermatology-myths/22036/Here are the facts about seven common misconceptions that may hinder effective patient care.